STAT3 and hepatocellular carcinoma: Besides, transformed hepatocytes rely on STAT3 expression in hepatocellular carcinoma (Jung et al., 2017), and iExosomes targeting STAT3 in liver could also offer benefits in attenuating progression (Lou et al., 2020).